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Abstract
Cocaine has become the most frequently used illicit drug among patients presenting to emer-
gency departments worldwide. Although acute myocardial infarction is the most common
reported cardiovascular manifestation in this setting, there are many other potential cardio-
toxic effects of cocaine use including coronary artery spasm, arrhythmia, and sudden death.
We report the case of a 54 year-old male with angiographically documented reversible coronary
arterial spasm leading to severe life-threatening recurrent ventricular arrhythmias and
electrocardiographic changes suggesting acute myocardial infarction secondary to cocaine use.
Recurrent ventricular arrhythmias of this patient required implantation of a cardioverter-defi-
brillator which successfully treated following arrhythmia episodes. (Cardiol J 2010; 17, 5: 512–517)
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Introduction
Cocaine use is a growing problem worldwide.
As a result, the number of cocaine-related emer-
gency department visits, hospital admissions and
deaths have increased. Acute myocardial infarction
(MI) is the most common cardiac consequence of
cocaine use, but significant arrhythmias are also re-
ported [1]. The early diagnosis of cocaine-associat-
ed cardiovascular complications are essential for
appropriate management. The etiology of cocaine-
-induced myocardial ischemia is complex and mul-
tifactorial [2]. Cocaine appears to cause acute myo-
cardial ischemia or infarction in patients with and
without pre-existing coronary artery disease. By
means of the presented case, this paper focuses on
the diagnosis and treatment of cardiovascular
events in cocaine users.
Case report
Five years ago, a 54 year-old man was admit-
ted to the emergency room complaining of severe
chest pain. He had no established cardiovascular
risk factor. However, his family warned us that he
was a cocaine addict, usually via the powder form
by nasal insufflation. Physical examination revealed
a blood pressure of 110/70 mm Hg and irregular
pulse 151 bpm without additional pathologic find-
ings. Initial electrocardiogram (ECG) evaluation
demonstrated atrial fibrillation with rapid ventri-
cular response and 1 mm ST depression in deriva-
tions V4–V6. Admission troponin T level was slight-
ly increased (0.42 ng/mL) and other laboratory pa-
rameters were normal. The patient was managed
as acute coronary syndrome and was scheduled for
coronary angiography the next day. Meanwhile,
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after administration of intravenous beta blocker for
rate control, atrial fibrillation resolved spontaneous-
ly in the coronary care unit. The patient was dis-
charged on acetylsalicilic acid treatment based on
a coronary angiography result indicating non-signifi-
cant coronary artery disease (only a plaque was
determined in mid left anterior descending artery)
and normal left ventriculography. He was informed
of his condition in detail and of the effects of cocaine
on the heart. He was encouraged to stop using co-
caine, advised to seek medical help from a psychia-
trist experienced in treating drug addicts, and ar-
ranged an appointment after discharge. However,
on the following day the patient was readmitted to
the emergency department with severe prolonged
chest pain and palpitation. His ECG demonstrated
ST segment elevation in inferior and right ventri-
cular derivations (Fig. 1) with reciprocal changes
in lateral derivations. Subsequently, cardiac arrest
related to ventricular fibrillation developed in the
emergency room. After defibrillation and resusci-
tation, the patient was transferred to the cath lab
for primary percutaneous intervention. Coronary
angiography revealed a long and severe stenosis in
the mid and distal portions of the right coronary
artery. Administration of nitroglycerin resolved this
severe narrowing and ST elevation was normalized
suggesting a vasospastic phenomenon. Echocardio-
graphic examination showed mild inferior hypoki-
nesia, with a left ventricular ejection fraction of 58%.
After an uneventful clinical course, the patient was
discharged on maximum tolerable dose of oral ni-
trate therapy and registered for a detox program.
One month later, the patient was readmitted
to the emergency department with cardiac arrest
due to recurrent ventricular fibrillation. After
defibrillation and cardiopulmonary resuscitation, bi-
carbonate and lidocaine therapy were administrat-
ed for arrhythmia management. Electrocardio-
graphy revealed mild ST segment elevation in an-
terior derivations. Based on the history of the
patient, and his unstable condition, an emergency
control coronary angiography was performed. This
time severe and diffuse narrowings through the
right coronary artery and the left main coronary
artery trunk were determined (Figs. 2, 3). The pres-
ence of a new stenosis which had been absent from
theprevious angiogram hinted at the diagnosis of
vasospasm, which was proved by the complete dis-
appearence of both lesions (Figs. 4, 5) after admin-
istration of intracoronary nitroglycerin to each coro-
nary ostea. Consequently, a calcium channel blocker
Figure 1. Electrocardiography (ECG) traces of the patient: 12-lead ECG (upper tracing) demonstrates ST segment
elevations in inferior derivations with reciprocal changes in lateral derivations, whereas ST segment elevation in
between V4R and V6R is apparent in right ventricular derivations (lower tracing) indicating an accompanying right
ventricular infarction.
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in maximum tolerable dose was added to the oral
nitrate treatment. He was advised to continue the
cocaine detox program.
Seventeen months later, during a hospital stay
for atypical chest pain complaints (while he was still
under double vasodilator therapy) the patient suf-
Figure 2. Coronary angiogram of the patient: right co-
ronary artery injection (in left oblique view) shows dif-
fuse narrowing throughout the whole coronary artery
which is prominent in the distal segment.
Figure 3. Coronary angiogram of the patient: left coro-
nary artery injection (in anteroposterior view) depicts dif-
fuse narrowing in the left main coronary artery trunk. Also
a plaque is noted in mid-portion of left anterior descend-
ing coronary artery which is concordant with the one
described in the previous angiography of the patient.
Figure 5. Coronary angiogram of the patient: after ad-
ministration of selective intracoronary nitrate, left coro-
nary artery injection (in right caudal view) demonstrates
that vasospasm in the left main coronary artery trunk
has resolved.
Figure 4. Coronary angiogram of the patient: after ad-
ministration of selective intracoronary nitrate, right co-
ronary artery injection (in left oblique view) proves the
relief of diffuse vasospasm in the right coronary artery
which has reached its original native diameter.
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fered an in-hospital ventricular fibrillation episode
and cardiac arrest. After resuscitation, his ECG
demonstrated normal findings without any eleva-
tion in serial cardiac troponin measurements. Due
to recurrent ventricular fibrillation under maximum
dosage of oral nitrate and calcium channel blocker
therapy, the patient underwent single chamber car-
dioverter-defibrillator (ICD) implantation and was
discharged from hospital four days after the proce-
dure. At the six month follow-up, interrogation of
the device revealed two episodes of ventricular ta-
chycardia which were effectively interrupted by
ICD. No subsequent adverse event was seen at the
12 month follow-up.
Discussion
As cocaine use has become widespread, co-
caine-related cardiovascular morbidity and morta-
lity have increased worldwide. It has been associa-
ted with various cardiovascular complications in-
cluding angina pectoris, MI, arrhythmia, heart failure
and sudden cardiac death [3]. There are several
proposed mechanisms for the cardiotoxic effects of
cocaine. Increased myocardial oxygen demand (by
increasing heart rate, blood pressure and contrac-
tility), coronary vasoconstriction, platelet activation
and accelerated premature atherosclerosis are pro-
posed mechanisms in patients with cocaine-induced
MI or ischemia [2, 3]. Cocaine-associated vasocon-
striction occurs via stimulation of the a-adrenergic
receptors on smooth muscle cells in the coronary
arterial bed [4]. Moreover increased endothelin and
decreased nitric oxide productions by the endothe-
lium related to cocaine use also contributes in vaso-
constriction and may further aggravate coronary
arterial spasm [5, 6]. It has been reported that even
recreational doses of cocaine are associated with
vasoconstriction of coronary arteries [2]. Although
MI or coronary vasoconstriction may be more ac-
centuated in patients with pre-existing coronary
artery disease, they had also been documented in
patients with normal coronary arteries [7].
There is also evidence that besides inducing
myocardial ischemia, cocaine can trigger cardiac ar-
rhythmias, probably as a result of the enhanced
sympathetic state and the direct effects on the
heart. Ventricular arrhythmias occurring immedia-
tely after cocaine use are more likely to result from
the local anesthetic effects on the myocardium, rath-
er than late onset arrhythmias which are generally
secondary to myocardial ischemia [8]. Cocaine in-
fluences alterations in ion channels (by blocking
potassium channels, increasing L-type calcium
channel current, and inhibiting sodium influx) re-
sulting in both repolarization and depolarization
abnormalities which makes the myocardium sus-
ceptible to different arrhythmias [3, 9]. Common
clinical manifestations of these electrophysiologi-
cal alterations involve QT prolongation on ECG,
idioventricular rhythms, wide complex tachycar-
dias, torsade de pointes and ventricular fibrillation
[9–11].
Chest pain is the commonest symptom in co-
caine users and accounts for approximately 16% of
all cocaine-related admissions [12]. Differential dia-
gnosis of cocaine-associated chest pain involves
musculosceletal complications, acute pulmonary
syndrome, pulmonary hypertension, aortic dissec-
tion and barotrauma-related injuries including pneu-
momediastinum, pneumothorax, and pneumoperi-
cardium related to cocaine use [13–16].
Evaluating cocaine-associated chest pain is
similar to evaluating patients with acute coronary
syndromes, and involves ECG, serial cardiac mark-
ers, and some forms of stress testing. The incidence
of cocaine-associated MI varies (0.7% to 6%) be-
tween studies implementing different diagnostic
criteria [8]. It has been reported that after cocaine
use, patients may present with chest pain similar
to angina pectoris and their electrocardiographic
ST segment changes mimic MI [17]. Although this
paper reports a low incidence of MI and favorable
in-hospital prognosis, it is worth noting that total
and MB fraction of creatine kinase was utilized to
confirm MI as the available biomarker at that time.
Cocaine ingestion may cause rhabdomyolysis with
consequent elevation in myoglobin and total creat-
ine kinase levels. Therefore cardiac troponins are
preferred markers for the diagnosis of cocaine-as-
sociated MI [8]. The use of standard ECG criteria
(ST elevation) alone for the diagnosis of an acute MI
in cocaine users is insufficient to determine adminis-
tration of fibrinolytic therapy. However percutaneous
coronary intervention should be the preferred ap-
proach, because it can precisely establish the diag-
nosis and additionally provides therapeutic options.
In the American Heart Association scientific
statement, some therapeutic options are recom-
mended in the management of cocaine-associated
chest pain and MI [8]. Nitroglycerin, verapamil and
phentolamine are the agents of choice in treating
patients with cocaine-associated chest pain or co-
caine-induced vasospasm. In our patient, severe
coronary spasm could be ascertained and rapidly
reversed with nitroglycerin injection during cardiac
catheterization. Benzodiazepines are also useful
in the relief of cocaine-associated chest pain by
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reducing the heart rate and arterial pressure. Long
acting nitrates and calcium channel blockers may
be used as long-term therapy to cure anginal symp-
toms, but are not indicated for routine use. Beta-
-blockers are not recommended (except for patients
with left ventricular dysfunction or coronary artery
disease) in the setting of cocaine abuse [3] because
of concerns about provoking coronary spasm.
The treatment of ventricular arrhythmias de-
pends on the interval between cocaine use and ar-
rhythmia onset. If an arrhythmia occurs immediately
after cocaine use, it will likely benefit from admini-
stration of sodium bicarbonate. On the other hand,
late onset arrhythmias are probably secondary to
myocardial ischemia associated with cocaine use
and vasodilator therapy should be the mainstay of
the treatment [8]. Standard management for ven-
tricular arrhythmias, including lidocaine, is reason-
able for persistent or recurrent ventricular arrhyth-
mias. In our patient, ventricular arrhythmias on the
first and second admissions were considered to be
related to ischemia associated with cocaine-induced
vasospasm. So nitrate and calcium channel block-
ers at maximum tolerable dose were prescribed for
long term management. Torsades de pointes or
QT prolongation that would be the mechanism of
cocaine-associated arrhythmia was not documented
in our patient.
We thought that the severe life-threatening ar-
rhythmia of the patient on his third admission was
probably a result of the enhanced sympathetic state
and the direct cardiotoxic effects of cocaine on the
heart. Therefore, a single chamber ICD implanta-
tion was performed for secondary prevention. Our
case shows that cocaine use can be associated with
severe life-threatening arrythmias with or without
myocardial infarction caused by coronary vaso-
spasm. There are no extensive specified reports on
ICD implantation and its benefits in cocaine addicts.
But according to a restrospective report [18], clini-
cians should consider and be aware of the possibil-
ity of increased defibrillation thresholds in cocaine
users, something which was also verified in our case
(31 joules).
Cocaine use can be ascertained by self-report
or by urine, blood and hair analysis. Self-reported
use of cocaine can be obtained easily. However
a potential significant drawback is under-reporting
by patients. Quantitative methods are more expen-
sive, and also potentially misleading because of in-
dividual variability in cocaine metabolism and ex-
cretion [19]. Secondary prevention by detox pro-
grams may reduce cardiovascular and other
morbidity associated with cocaine use. Recurrent
chest pain, MI and deaths are frequent among pa-
tients who continue to use cocaine [7]. In the pre-
sented case, detox attempts were unsuccessful and
the patient was still using cocaine on each hospital
admission which was responsible for recurrent car-
diovascular events. We should underline that detox
programs should be the mainstay of management
for cocaine addicts. ICD implantation should be con-
sidered only for a select group of patients who have
cardiomyopathy and low ejection fraction related to
cocaine use, or in patients for whom detox programs
have failed to cease their use of cocaine and who
have recurrent ventricular arrhythmias.
Conclusions
Cocaine use can cause lethal cardiovascular
events including MI and ventricular arrhythmias.
The possibility of cocaine use should be seriously
considered in any young patient with minimal risk
factors for cardiac disease presenting with MI and
cardiac arrhythmias. The prognosis of patients with
cardiovascular manifestations depends on whether
they cease using cocaine or not. Our case indicates
that implantation of an implantable cardioverter-
-defibrillator is an option for addicts presenting with
recurrent ventricular tachycardia or fibrillation who
cannot cease using cocaine by detox programs.
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